Trial | NCT02845388  Report issue

Title

Sildenafil Citrate in Frozen Embryo Transfer
Sildenafil Citrate for Endometrial Preparation in Frozen-thawed Embryo Transfer Cycles

  • Phase

    Phase 2

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    90
Comparison between usage of Sildenafil citrate with estradiol valerate or estradiol valerate alone in endometrial preparation and outcome of frozen-thawed embryo transfer cycles.
Study Started
Sep 30
2015
Primary Completion
May 31
2016
Study Completion
Jun 30
2016
Last Update
Jul 27
2016
Estimate

Drug Sildenafil citrate

  • Other names: Viagra

Drug estradiol valerate

estradiol valerate Active Comparator

estradiol valerate 2mg every 12 hours orally starting from the second day of the menstrual cycle till reaching trilaminar endometrial pattern and endometrial thickness 8 mm or more

Sildenafil citrate and estradiol valerate Active Comparator

Sildenafil citrate 25 mg every 6 hours orally in combination with estradiol valerate 2mg every 12 hours orally starting from the second day of the menstrual cycle till reaching trilaminar endometrial pattern and endometrial thickness 8 mm or more

Criteria 

Inclusion Criteria:

all cases have at least 2 good quality blastocysts available for transfer

Exclusion Criteria:

uterine structural abnormalities
advanced uterine disease
hydrosalpinx and pyosalpinx
No Results Posted